Clinical Trials List
Protocol Number111393（MENACWY-TT-080 BST：10PN-PD-DIT-029/031）
2008-09-20 - 2010-02-28
Phase III
Terminated2
-
Trial Applicant
GlaxoSmithKline
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 鄒宗珮 Division of Pediatrics
- 楊清棋 Division of Pediatrics
- Chun-yi Lu Division of Pediatrics
- 吳佩潔 Division of Pediatrics
- Luan-Yin Chang Division of Pediatrics
- 徐千惠 Division of Pediatrics
- 蔡漢生 Division of Pediatrics
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 林瑞瑩 Division of Pediatrics
- Jen Fu Hsu Division of Pediatrics
- 郭貞孍 Division of Pediatrics
- 黃宣蓉 Division of Pediatrics
- 詹美齡 Division of Pediatrics
- Cheng-Hsun Chiu Division of Pediatrics
- Ru-Li Lin Division of Pediatrics
- 翁逸豪 Division of Pediatrics
- 段寶蘭 Division of Pediatrics
- 顏盟修 Division of Pediatrics
- Yhu-Chering Huang Division of Pediatrics
- 朱世明 Division of Pediatrics
- 黃冠穎 Division of Pediatrics
- 梁景祥 Division of Pediatrics
- Da-Chin Yan Division of Pediatrics
- 楊鵬弘 Division of Pediatrics
- 傅仁煇 Division of Pediatrics
- 李浩遠 Division of Pediatrics
- 李文珍 Division of Pediatrics
- 江明洲 Division of Pediatrics
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
230 participants
-
Global
460 participants
